|
1
|
Wang K, Long B, Liu F, Wang JX, Liu CY,
Zhao B, Zhou LY, Sun T, Wang M, Yu T, et al: A circular RNA
protects the heart from pathological hypertrophy and heart failure
by targeting miR-223. Eur Heart J. 37:2602–2611. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jakobi T, Czaja-Hasse LF, Reinhardt R and
Dieterich C: Profiling and validation of the circular RNA
repertoire in adult murine hearts. Genomics Proteomics
Bioinformatics. 14:216–223. 2016. View Article : Google Scholar :
|
|
3
|
Xu S, Zhou L, Ponnusamy M, Zhang L, Dong
Y, Zhang Y, Wang Q, Liu J and Wang K: A comprehensive review of
circRNA: From purification and identification to disease marker
potential. PeerJ. 6:e55032018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li JJ, Wang W, Wang XQ, He Y, Wang SS and
Yan YX: A novel strategy of identifying circRNA biomarkers in
cardiovascular disease by meta-analysis. J Cell Physiol.
234:21601–21612. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fan X, Weng X, Zhao Y, Chen W, Gan T and
Xu D: Circular RNAs in cardiovascular Disease: An overview. Biomed
Res Int. 2017:51357812017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Burd CE, Jeck WR, Liu Y, Sanoff HK, Wang Z
and Sharpless NE: Expression of linear and novel circular forms of
an INK4/ARF-associated non-coding RNA correlates with
atherosclerosis risk. PLoS Genet. 6:e10012332010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Memczak S, Jens M, Elefsinioti A, Torti F,
Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer
M, et al: Circular RNAs are a large class of animal RNAs with
regulatory potency. Nature. 495:333–338. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Du WW, Yang W, Chen Y, Wu ZK, Foster FS,
Yang Z, Li X and Yang BB: Foxo3 circular RNA promotes cardiac
senescence by modulating multiple factors associated with stress
and senescence responses. Eur Heart J. 38:1402–1412. 2017.
|
|
9
|
Zhou Q, Zhang Z, Bei Y, Li G and Wang T:
Circular RNAs as novel biomarkers for cardiovascular diseases. Adv
Exp Med Biol. 1087:159–170. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang L, Meng X, Li G, Zhou Q and Xiao J:
Circular RNAs in cardiovascular diseases. Adv Exp Med Biol.
1087:191–204. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tan WL, Lim BT, Anene-Nzelu CG,
Ackers-Johnson M, Dashi A, See K, Tiang Z, Lee DP, Chua WW, Luu TD,
et al: A landscape of circular RNA expression in the human heart.
Cardiovasc Res. 113:298–309. 2017.PubMed/NCBI
|
|
12
|
Altesha MA, Ni T, Khan A, Liu K and Zheng
X: Circular RNA in cardiovascular disease. J Cell Physiol.
234:5588–5600. 2019. View Article : Google Scholar
|
|
13
|
Kristensen LS, Andersen MS, Stagsted L,
Ebbesen KK, Hansen TB and Kjems J: The biogenesis, biology and
characterization of circular RNAs. Nat Rev Genet. 20:675–691. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bayoumi AS, Aonuma T, Teoh JP, Tang YL and
Kim IM: Circular noncoding RNAs as potential therapies and
circulating biomarkers for cardiovascular diseases. Acta Pharmacol
Sin. 39:1100–1109. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
von Harsdorf R, Li PF and Dietz R:
Signaling pathways in reactive oxygen species-induced cardiomyocyte
apoptosis. Circulation. 99:2934–2941. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fu Y, Liu X, Zhang F, Jiang S, Liu J and
Luo Y: Bortezomib-inducible long non-coding RNA myocardial
infarction associated transcript is an oncogene in multiple myeloma
that suppresses miR-29b. Cell Death Dis. 10:3192019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang K, Li W, Duan W, Jiang Y, Huang N, Li
Y, Ren B and Sun J: Resveratrol attenuates pulmonary embolism
associated cardiac injury by suppressing activation of the
inflammasome via the MALAT1miR223p signaling pathway. Int J Mol
Med. 44:2311–2320. 2019.PubMed/NCBI
|
|
18
|
Kruger J and Rehmsmeier M: RNAhybrid:
microRNA target prediction easy, fast and flexible. Nucleic Acids
Res. 34(Web Server Issue): W451–W454. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sticht C, De La Torre C, Parveen A and
Gretz N: miRWalk: An online resource for prediction of microRNA
binding sites. PLoS One. 13:e2062392018. View Article : Google Scholar
|
|
20
|
Wang S, Ye L and Wang L: Protective
mechanism of shenmai on myocardial ischemia-reperfusion through the
energy metabolism pathway. Am J Transl Res. 11:4046–4062.
2019.PubMed/NCBI
|
|
21
|
Pan JA, Tang Y, Yu JY, Zhang H, Zhang JF,
Wang CQ and Gu J: miR-146a attenuates apoptosis and modulates
autophagy by targeting TAF9b/P53 pathway in doxorubicin-induced
cardio-toxicity. Cell Death Dis. 10:6682019. View Article : Google Scholar
|
|
22
|
Barwari T, Joshi A and Mayr M: MicroRNAs
in cardiovascular disease. J Am Coll Cardiol. 68:2577–2584. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Romaine SP, Tomaszewski M, Condorelli G
and Samani NJ: MicroRNAs in cardiovascular disease: An introduction
for clinicians. Heart. 101:921–928. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Schulte C, Karakas M and Zeller T:
microRNAs in cardiovascular disease-clinical application. Clin Chem
Lab Med. 55:687–704. 2017. View Article : Google Scholar
|
|
25
|
Wang K, Gan TY, Li N, Liu CY, Zhou LY, Gao
JN, Chen C, Yan KW, Ponnusamy M, Zhang YH and Li PF: Circular RNA
mediates cardiomyocyte death via miRNA-dependent upregulation of
MTP18 expression. Cell Death Differ. 24:1111–1120. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Aufiero S, Reckman YJ, Pinto YM and
Creemers EE: Circular RNAs open a new chapter in cardiovascular
biology. Nat Rev Cardiol. 16:503–515. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
E S, Costa MC, Kurc S, Drożdż A,
Cortez-Dias N and Enguita FJ: The circulating non-coding RNA
landscape for biomarker research: Lessons and prospects from
cardiovascular diseases. Acta Pharmacol Sin. 39:1085–1099. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Roush S and Slack FJ: The let-7 family of
microRNAs. Trends Cell Biol. 18:505–516. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Balzeau J, Menezes MR, Cao S and Hagan JP:
The LIN28/let-7 pathway in cancer. Front Genet. 8:312017.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bao MH, Feng X, Zhang YW, Lou XY, Cheng Y
and Zhou HH: Let-7 in cardiovascular diseases, heart development
and cardiovascular differentiation from stem cells. Int J Mol Sci.
14:23086–23102. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhou X, Sun F, Luo S, Zhao W, Yang T,
Zhang G, Gao M, Lu R, Shu Y, Mu W, et al: Let-7a is an
antihypertrophic regulator in the heart via targeting calmodulin.
Int J Biol Sci. 13:22–31. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Seeger T, Xu QF, Muhly-Reinholz M, Fischer
A, Kremp EM, Zeiher AM and Dimmeler S: Inhibition of let-7 augments
the recruitment of epicardial cells and improves cardiac function
after myocardial infarction. J Mol Cell Cardiol. 94:145–152. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Suarez Y, Fernandez-Hernando C, Pober JS
and Sessa WC: Dicer dependent microRNAs regulate gene expression
and functions in human endothelial cells. Circ Res. 100:1164–1173.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cao L, Kong LP, Yu ZB, Han SP, Bai YF, Zhu
J, Hu X, Zhu C, Zhu S and Guo XR: microRNA expression profiling of
the developing mouse heart. Int J Mol Med. 30:1095–1104. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lederer M, Bley N, Schleifer C and
Huttelmaier S: The role of the oncofetal IGF2 mRNA-binding protein
3 (IGF2BP3) in cancer. Semin Cancer Biol. 29:3–12. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bhargava S, Patil V, Shah RA and
Somasundaram K: IGF2 mRNA binding protein 3 (IMP3) mediated
regulation of transcriptome and translatome in glioma cells. Cancer
Biol Ther. 19:42–52. 2018. View Article : Google Scholar :
|
|
37
|
Shimizu T, Sugihara E, Yamaguchi-Iwai S,
Tamaki S, Koyama Y, Kamel W, Ueki A, Ishikawa T, Chiyoda T, Osuka
S, et al: IGF2 preserves osteosarcoma cell survival by creating an
autophagic state of dormancy that protects cells against
chemotherapeutic stress. Cancer Res. 74:6531–6541. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Nishida K, Yamaguchi O and Otsu K:
Crosstalk between autophagy and apoptosis in heart disease. Circ
Res. 103:343–351. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Takemura G, Kanamori H, Okada H, Miyazaki
N, Watanabe T, Tsujimoto A, Goto K, Maruyama R, Fujiwara T and
Fujiwara H: Anti-apoptosis in nonmyocytes and pro-autophagy in
cardiomyocytes: Two strategies against postinfarction heart failure
through regulation of cell death/degeneration. Heart Fail Rev.
23:759–772. 2018. View Article : Google Scholar : PubMed/NCBI
|
